NCT04770610 - Study of OT-101 in Treating Myopia | Biotech Hunter

Enrollment

678

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

March 31, 2027

Study Completion Date

April 30, 2027

Conditions

Myopia, Progressive

Interventions

DRUG

OT-101 Ophthalmic Solution

Atropine 0.01%

DRUG

Vehicle

Investigational Product minus active ingredient

Trial Locations (15)

15224

UPMC Children's Hospital, Pittsburgh

16066

Scott & Christie and Associates, Cranberry Township

16501

Pediatric Ophthalmology of Erie, Inc, Erie

20850

Kids Eye Care of Maryland, Rockville

28150

CORE, Inc., Shelby

28227

Pure Ophthalmic Research, Mint Hill

32202

Pediatric Eye Consultants of North Florida, Jacksonville

32607

Family Focus, Gainesville

38119

Total Eye Care, P.A., Memphis

44106

University Hospitals Cleveland Medical Center, Cleveland

46202

Indiana University Health Physicians Pediatric Ophthalmology, Indianapolis

63090

Comprehensive Eye Care, Ltd., Washington

78215

San Antonio Eye Center, San Antonio

80528

Eye Center of Northern Colorado, PC, Fort Collins

80907

Colorado Vision Institute, Colorado Springs

All Listed Sponsors

collaborator

ORA, Inc.

INDUSTRY

collaborator

Statistics & Data Corporation

INDUSTRY

lead

Ocumension (Hong Kong) Limited

OTHER